Results 191 to 200 of about 422,254 (308)

Probiotic Bacteria as Therapeutics and Biohybrid Drug Carriers: Advances, Design Strategies, and Future Outlook. [PDF]

ACS Appl Bio Mater
Sahoo D, Rodriguez E, Nguyen K, Chintapula U.   +3 more
europepmc   +1 more source

Lipoproteins as Drug Carriers for Cyclosporine A: Optimization of the Entrapment. [PDF]

Materials (Basel), 2023
Abdel-Mottaleb MMA, Boi L, Barra M, Colin J, Berni L, Béduneau A, Moulari B, Pellequer Y.   +7 more
europepmc   +1 more source

Re‐Awakening Public Attention to the Silent Pandemic of Cancer Among Older Adults in Low‐ and Middle‐Income Countries

Aging and Cancer, EarlyView.
ABSTRACT As global populations age, cancer is increasingly becoming a leading cause of morbidity and mortality among older adults, particularly in low‐ and middle‐income countries (LMICs). Despite accounting for the majority of new cancer cases and deaths, older individuals remain underrepresented in cancer research, clinical guidelines, and health ...
Ibrahim Bidemi Abdullateef, Sunkanmi Folorunsho, Abdulazeez Opeyemi Abdulganiyu   +2 more
wiley   +1 more source

Hydrogels as a new platform of therapeutic systems in oncological treatment - use as a protective barrier and drug carriers. [PDF]

Front Bioeng Biotechnol
Czerwiec K, Szczecińska W, Pikuła M.
europepmc   +1 more source

Biocompatible Glycol Chitosan Microgels as Effective Drug Carriers. [PDF]

Gels, 2023
Sahiner M, Yilmaz AS, Ayyala RS, Sahiner N.   +3 more
europepmc   +1 more source

Aging Is a Key Driver for Adult Acute Myeloid Leukemia

Aging and Cancer, EarlyView.
Acute myeloid leukemia (AML) is a classical age‐related hematologic malignancy, and a key driver of AML is aging, which profoundly regulates intrinsic factors such as genomic instability, epigenetic reprogramming, and metabolic dysregulation, and alters bone marrow microenvironment.
Rong Yin, Haojian Zhang
wiley   +1 more source

Mucosomes as next-generation drug carriers for treating mucus-resident bacterial infections and biofilms. [PDF]

Sci Rep
Guagliano G, Peluso E, Butnarasu CS, Restivo E, Sardelli L, Frasca E, Petrini P, Tirelli N, Sganga S, Visai L, Visentin S.   +10 more
europepmc   +1 more source

Semifluorinated Alkanes as New Drug Carriers-An Overview of Potential Medical and Clinical Applications. [PDF]

Pharmaceutics, 2023
Tsagogiorgas C, Otto M.
europepmc   +1 more source

Mutant NPM1 in Acute Myeloid Leukemia Initiation and Maintenance

Aging and Cancer, EarlyView.
NPM1 mutations drive acute myeloid leukemia by acting as neomorphic transcriptional regulators that cooperate with Menin–MLL and XPO1 to sustain HOX/MEIS1 expression and block differentiation. Targeting these mutant‐specific transcriptional dependencies provides a rational therapeutic strategy for NPM1‐mutated AML.
Yanan Jiang, Zhong Fan, Runmeng Liu, Xiaotian Zhang   +3 more
wiley   +1 more source

Phytonanoparticles as novel drug carriers for enhanced osteogenesis and osseointegration. [PDF]

Discov Nano
Suresh N, Thomas NG, Mauramo M, Waltimo T, Sorsa T, Anil S.   +5 more
europepmc   +1 more source